Lotte Biologics vs Merck KGaA / MilliporeSigma (CDMO): CDMO Comparison
How does Lotte Biologics compare to Merck KGaA / MilliporeSigma (CDMO) for Biologics manufacturing?
Side-by-side comparison of Lotte Biologics and Merck KGaA / MilliporeSigma (CDMO) on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates; Lotte Biologics does not appear in EudraGMDP.
- Merck KGaA / MilliporeSigma (CDMO) appears as a manufacturing partner on more matched clinical programs (22 vs 0) — a broader sponsor book.
On a 13-modality CDMO landscape, both Lotte Biologics and Merck KGaA / MilliporeSigma (CDMO) qualify as Biologics manufacturers; Lotte Biologics carries the higher composite Signal Score for Biologics programs in this comparison.
What to evaluate for Biologics programs
Both Lotte Biologics and Merck KGaA / MilliporeSigma (CDMO) qualify as Biologics CDMOs. When choosing between them for Biologics programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Scale & bioreactor fit
Match validated bioreactor scale (from a few hundred litres clinical to 2,000L+ commercial) and single-use vs stainless to your dose and indication. Confirm titer expectations for your construct.
Cell line & process development
Ask whether the CDMO offers its own expression platform/cell line or works from yours, and how process development and tech transfer are handled.
Regulatory track record
Biologics programs heading to BLA/MAA need a strong commercial-scale inspection history. Cross-check FDA 483s, warning letters, and EMA/MHRA GMP coverage — all shown above.
Drug substance to drug product
Confirm whether the CDMO covers fill-finish and formulation in-house or coordinates a separate site, which affects timelines and comparability.
Frequently asked: Lotte Biologics vs Merck KGaA / MilliporeSigma (CDMO)
How does Lotte Biologics compare to Merck KGaA / MilliporeSigma (CDMO) for Biologics manufacturing?
On CDMO Signal's composite Signal Score, Lotte Biologics is 84/100 and Merck KGaA / MilliporeSigma (CDMO) is 82/100; Lotte Biologics has 1 FDA inspection on record vs 2 for Merck KGaA / MilliporeSigma (CDMO); European coverage is 0 active EMA+MHRA certificates for Lotte Biologics vs 2 for Merck KGaA / MilliporeSigma (CDMO). Both are tracked in the CDMO Signal directory as Biologics CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Lotte Biologics or Merck KGaA / MilliporeSigma (CDMO)?
Both Lotte Biologics and Merck KGaA / MilliporeSigma (CDMO) maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Lotte Biologics has 1 FDA inspection on record; Merck KGaA / MilliporeSigma (CDMO) has 2.
How do Lotte Biologics and Merck KGaA / MilliporeSigma (CDMO) compare on European GMP coverage?
Lotte Biologics holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — Lotte Biologics or Merck KGaA / MilliporeSigma (CDMO)?
Lotte Biologics is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Merck KGaA / MilliporeSigma (CDMO) is matched to 22. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for Biologics manufacturing — Lotte Biologics or Merck KGaA / MilliporeSigma (CDMO)?
Both Lotte Biologics and Merck KGaA / MilliporeSigma (CDMO) are tagged as Biologics CDMOs in our directory, so both are credible options for Biologics programs. The most important differentiator for Biologics selection is typically scale & bioreactor fit: Match validated bioreactor scale (from a few hundred litres clinical to 2,000L+ commercial) and single-use vs stainless to your dose and indication. Confirm titer expectations for your construct. Review each CDMO's profile and inspection record before shortlisting.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →